Skip to main content
  1. Contributors/

Prof. Dr. Gabriele Ende

Principal investigator Research data committee member Quality control group member

Department Neuroimaging, Central Institute of Mental Health (ZI), Mannheim, and Medical Faculty, Ruprecht-Karls University Heidelberg

0000-0002-8778-771X

Gabriele Ende

Gabriele Ende is a researcher associated with the Central Institute of Mental Health (ZI) in Mannheim, Germany. Her work primarily focuses on neuroimaging and the application of magnetic resonance spectroscopy (MRS) in psychiatric and neurological disorders. Ende’s research aims to deepen the understanding of brain chemistry and its alterations in various mental health conditions.

Related content

Projects


A03: Modulation of aggression by acute threat

The neural and neurochemical patterns of acute threat as modulators of aggression in BPD will be investigated in this project. The modulation of aggressive responses under acute threat is induced by the threat-of-shock paradigm. The main translational research question is if and how aggressive responses are modulated by threat, and which neurofunctional and neurochemical patterns underlie these responses during safe and threat conditions. MR spectroscopy will be used in patients to assess glutamate and GABA levels. In a further translational approach, the least and the most aggressive/impulsive recombinant inbred mouse lines identified in C01 in Frankfurt will be tested in Mannheim with animal MR spectroscopy at 9.4T to determine the relationship between glutamate, GABA, impulsivity, and aggression in these mouse lines as well as in comparable brain regions assessing neurofunctional and neurochemical patterns.

A08: The metabolic lung-brain axis in aggressive behavior in patients with AMD

Beta-hydroxy-butyrate (BHB), a ketone body, is negatively associated with aggressive behavior. BHB is a metabolite and an active signaling substrate involved in epigenetic regulation of e.g., neurotrophic factor genes in the brain. Of the three main ketone bodies, acetone, acetoacetate and BHB, acetone is a very volatile compound, mainly eliminated through respiration, thus can be measured non-invasively in breath. A reduction of acetone in breath has been found to highly correlate with BHB in blood and be associated with symptom severity in schizophrenia (Jiang et al. 2022). Using MR spectroscopy, A08 aims to (1) identify whether acetone and other volatile organic compounds in breath are associated with aggression and acute threat processing in mental disorders and (2) to examine whether these breath markers are associated with direct metabolic brain correlates (like BHB, glutamate) and with the brain-derived neurotrophic factor (BDNF) levels in plasma. In a translational approach, (3) we will test if supplementation of BHB reduces aggressive behavior in mice.

Q02: Data management for computational modelling

Data management and training platform. A decentralized data management infrastructure will help focus on developmental and therapeutic longitudinal data, training all participating researchers in the necessary skills for future use. This strategy will lay the foundations for further data-driven computational modelling projects in the next funding period.

This is a distributed project, with representatives at all main TRR379 sites.

Sites


Heidelberg University

Heidelberg University is Germany’s oldest university, founded in 1386. Renowned for its research excellence and strong emphasis on the humanities, natural sciences, and medicine, it consistently ranks among Europe’s top universities. The university fosters a rich academic tradition and an international outlook, attracting students and scholars from around the world.

Central Institute of Mental Health

The Central Institute of Mental Health (Zentralinstitut für Seelische Gesundheit) in Mannheim, Germany, is a leading psychiatric research institution affiliated with Heidelberg University. It specializes in research, treatment, and education related to mental health disorders, neuroscience, and psychosocial factors influencing mental well-being. The institute plays a crucial role in advancing psychiatric knowledge and developing innovative therapies through interdisciplinary collaboration and state-of-the-art facilities.